Concepedia

E. Marcel van Gelderen

EM

12

Publications

445

Citations

11

H-Index

1982

Active since

Affiliations

Astellas Pharma (United States)(Current)

Center for Global Development

Astellas Pharma (Netherlands)

Astellas Pharma (Japan)

Imperial College London

E. Marcel van Gelderen is an author at Astellas Pharma (United States) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1982–2015

12

Publications

12

Proarrhythmic Safety of Repeat Doses of Mirabegron in Healthy Subjects: A Randomized, Double-Blind, Placebo-, and Active-Controlled Thorough QT Study

Marek Malík, E. Marcel van Gelderen, J H Lee et al. · Clinical Pharmacology & Therapeutics · 2012 · 147 citations

QT/RR curvatures in healthy subjects: sex differences and covariates

Marek Malík, Katerina Hnatkova, Donna Kowalski et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2013 · 67 citations · Full text

, , +19

Haemodynamic changes and acetylcholine‐induced hypotensive responses after N<sup>G</sup>‐nitro‐<scp>l</scp>‐arginine methyl ester in rats and cats

E. Marcel van Gelderen, Jan P.C. Heiligers, Pramod R. Saxena · British Journal of Pharmacology · 1991 · 43 citations · Full text

Importance of subject-specific QT/RR curvatures in the design of individual heart rate corrections of the QT interval

Marek Malík, Katerina Hnatkova, Donna Kowalski et al. · Journal of Electrocardiology · 2012 · 35 citations

, , +11

Hypotensive activity of serotonin antagonists; correlation with α1 -adrenoceptor and serotonin receptor blockade

Hans O. Kalkman, Yvette M. Harms, E. Marcel van Gelderen et al. · Life Sciences · 1983 · 32 citations

, , +8

Rows per page

1–5 of 12